ezobresib (BMS-986158) / BMS 
Welcome,         Profile    Billing    Logout  
 0 Diseases   3 Trials   3 Trials   24 News 
4 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ezobresib (BMS-986158) / BMS
2021-005167-51: A trial to determine the safety of CC-92480 when combined with novel compounds in people who have Multiply Myeloma that is not responsive after treatment or has returned after a period of treatment Un ensayo para determinar la seguridad de CC-92480 cuando se combina con compuestos novedosos en personas con mieloma múltiple que no responde después del tratamiento o ha regresado después de un período de tratamiento

Not yet recruiting
1/2
60
Europe
CC-92480, BET-Inhibitor, Tazemetostat (Tazverik), Trametinib Mekinist, Dexamethasone, BMS-986158, TMT212, Capsule, hard, Capsule, Tablet, Tazemetostat (Tazverik), Trametinib Mekinist
Celgene Corporation, Celgene Corporation
Relapsed or Refractory Multiple Myeloma (RRMM) Mieloma múltiple recidivante o resistente (MMRR), Cancer of plasma cells Cancer de células plasmáticas, Diseases [C] - Cancer [C04]
 
 
CA011-023, NCT04817007 / 2020-002071-35: A Study to Assess the Safety and Tolerability of BMS-986158 Alone and in Combination With Either Ruxolitinib or Fedratinib in Participants With Blood Cancer (Myelofibrosis)

Active, not recruiting
1/2
216
Europe, US, RoW
BMS-986158, Ruxolitinib, Jakafi®, Fedratinib
Bristol-Myers Squibb, Bristol-Myers Squibb International Corporation
Myelofibrosis
05/26
05/26
CA057-003, NCT05372354: A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma

Recruiting
1/2
220
Europe, Canada, US
CC-92480, BMS-986348, Tazemetostat, BMS-986158, Trametinib, Dexamethasone
Bristol-Myers Squibb
Multiple Myeloma
10/26
10/26
NCT03936465: Study of the Bromodomain (BRD) and Extra-Terminal Domain (BET) Inhibitors BMS-986158 and BMS-986378 in Pediatric Cancer

Active, not recruiting
1
41
Canada, US
BMS-986158, BMS-986378, CC-90010
Dana-Farber Cancer Institute, Stand Up To Cancer
Solid Tumor, Childhood, Lymphoma, Brain Tumor, Pediatric
07/24
07/24

Download Options